Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7500 p527-532
3 May 2008

This section
Reprint   Photocopy

PDF 170K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: 527   528   529   530   531   532 

527 Hospital pharmacists to be at centre of HCAI checks Hospital pharmacists in England will find themselves at the centre of spot checks on the quality of infection control practices in acute trusts, it was announced by the Healthcare Commission last week
PJ 2008;280:527
Full Text

527 Guild’s parent union rejects three-year pay deal for NHS employees Proposals for a three-year pay deal for NHS staff have been rejected by the union that includes the Guild of Healthcare Pharmacists
PJ 2008;280:527
Full Text



528 Society accused of putting itself before the public The Royal Pharmaceutical Society was this week accused of putting self-interest ahead of the needs of the public by the Pharmacists’ Defence Association, an accusation disputed by the Society
PJ 2008;280:528
Full Text

528 Pharmacists should not be disciplined for single errors, guild agrees Pharmacists who make one-off dispensing errors should not routinely be subject to Royal Pharmaceutical Society disciplinary procedures, the Guild of Healthcare Pharmacists has said
PJ 2008;280:528
Full Text

528 Boots man to chair the National Pharmacy Association Paul Bennett, professional standards director and superintendent pharmacist at Boots, has been appointed chairman of the National Pharmacy Association
PJ 2008;280:528
Full Text

528 Boots healthcare director urges pharmacists to vote for company candidates Boots UK’s healthcare director Tricia Kennerley has urged pharmacists employed by Boots to vote for their colleagues who are seeking election to the Royal Pharmaceutical Society’s Council or English National Board
PJ 2008;280:528
Full Text



529 MHRA issues alert but Clexane will not be recalled Batches of Clexane (enoxaparin sodium; Sanofi-Aventis) containing low-levels of a contaminant called over-sulphated chondroitin sulphate (OSCS) have been distributed in the UK, the Medicines and Healthcare products Regulatory Agency announced last week
PJ 2008;280:529
Full Text

529 Minimise use of heparin flushes, says NPSA Use of heparin flush solutions in all devices should be minimised following a Rapid Response Report issued by the National Patient Safety Agency last week. The guidance is relevant to all healthcare professionals who are prescribing, dispensing or administering intravenous flush solutions to NHS patients
PJ 2008;280:529
Full Text

529 Updated practice guidance on hypertension published Updated practice guidance for community pharmacists on how to help patients to manage their hypertension has been published by the Royal Pharmaceutical Society and is distributed with this week’s Journal
PJ 2008;280:529
Full Text



530 “Ask your pharmacist” campaign kicks off with MUR support Raising consumer awareness of pharmacy services, such as medicines use reviews, health checks and sexual health services, is the aim of this year’s “Ask your pharmacist” campaign, launched by the National Pharmacy Association last week
PJ 2008;280:530
Full Text

530 White Paper could strengthen pharmacist-GP relationships Relationships between community pharmacy and general practice could be strengthened if the pharmacy White Paper is acted on sensibly, Howard Stoate, MP (Lab, Dartford), GP and All-Party Pharmacy Group chairman, indicated at an information prescriptions conference in London this week
PJ 2008;280:530
Full Text

530 Society’s annual review and accounts published ahead of annual general meeting The Royal Pharmaceutical Society’s annual review and full financial statements are distributed with this week’s issue of The Journal
PJ 2008;280:530
Full Text

530 Reported cases of influenza in Wales reach level that triggers antiviral use GPs in Wales have been told this week that they can prescribe neuraminidase inhibitors for patients with influenza in line with National Institute for Health and Clinical Excellence guidance
PJ 2008;280:530
Full Text



531 MPs’ report highlights pharmacy role in reducing antipsychotic use Community pharmacists could play a leading role in reducing inappropriate prescribing of antipsychotic drugs to people with dementia living in care homes, according to an influential parliamentary report published this week
PJ 2008;280:531
Full Text

531 Further evidence for bone risk with glitazones Additional evidence of a possible association between long-term use of thiazolidinediones and fractures in patients with diabetes mellitus has been published this week
PJ 2008;280:531
Full Text

531Mothers’ antiepilepsy drugs do not harm development of breastfed babies’ brains Breastfed babies whose mothers are taking certain antiepilepsy drugs do not suffer harmful effects in their cognitive development, early findings from a new study suggest
PJ 2008;280:531
Full Text

531 Anticholinergics and cognition Older people who take anticholinergic drugs appear to suffer more rapid cognitive decline than people who do not use these medicines, a study presented at a meeting of the American Academy of Neurology suggests
PJ 2008;280:531
Full Text

531 Check heart function in ADHD Children with attention deficit hyperactivity disorder should undergo cardiac evaluation before treatment with stimulant drugs, according to the American Heart Association
PJ 2008;280:531
Full Text

531 Risk of AF with alendronate Use of alendronate is associated with an increased risk of atrial fibrillation (AF), a new study suggests
PJ 2008;280:531
Full Text



532 Melatonin tops list of unlicensed products imported into the UK Melatonin treatments to tackle jet lag and sleep disturbance top the list of the most popular imported unlicensed products to the UK, according to statistics released by the Medicines and Healthcare products Regulatory Agency. Other lifestyle treatments that dominate the list include allergy patches, which are ranked sixth, followed by vitamin and topical supplements
PJ 2008;280:532
Full Text

532 Society’s Scottish office holds first open day The Royal Pharmaceutical Society’s Scottish office opened its doors for its inaugural open day on 27 April 2008
PJ 2008;280:532
Full Text

532 Problems with Medicines Complete access Problems that some multiple pharmacies in Scotland are having accessing Medicines Complete — the online pharmacy reference resource published by the Pharmaceutical Press — are being tackled by National Services Scotland
PJ 2008;280:532
Full Text

532 BTS and SIGN update asthma guidance Updated guidelines on the management of asthma have been published by the British Thoracic Society and the Scottish Intercollegiate Guidelines Network
PJ 2008;280:532
Full Text

532 Public health legislation New public health legislation in Scotland looks likely to be introduced following the passing of the first stage of the Public Health etc (Scotland) Bill
PJ 2008;280:532
Full Text

532 AMS hints and tips Hints, tips and frequently asked questions about the acute medication service (AMS) have been published by the Scottish Government
PJ 2008;280:532
Full Text

532 Norton settles Norton, one of several pharmaceutical companies accused of anticompetitive price fixing, has reached a settlement with the Scottish Government
PJ 2008;280:532
Full Text

Back to Top


©The Pharmaceutical Journal